Ana María Rojas Gómez

Ms. Ana María Rojas Gómez

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2022 in American Journal of Infection Control
Verified
Journal Article
Open access
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
FOFernando Otaiza
Fernando Otaiza
PRPablo Roson-Rodríguez
Pablo Roson-Rodríguez
AGAna María Rojas Gómez
Ana María Rojas Gómez
MGMarcelo Galas
Marcelo Galas
PRPilar Ramón-Pardo
Pilar Ramón-Pardo
This systematic review aims to summarize the evidence on the effects of screening strategies to detect carbapenem-resistant gram-negative bacteria (Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa). Eligible studies were randomized trials, non-randomized controlled trials, controlled before-after studies, and interrupted time series. We conducted searches in CENTRAL, PUBMED, Embase, Epistemonikos, and in multiple databases available in the Virtual Health Library (LILACS, Scielo, WHO IBECS, and PAHO IBECS). All the searches covered the period until 4 June 2021. No date or language restrictions were applied. Two reviewers independently evaluated potentially eligible studies according to predefined selection criteria, and extracted data on study characteristics, methods, outcomes, and risk of bias, using a predesigned standardized form. When possible, we intended to conduct meta-analyses using a random-effect model. We assessed the certainty of the evidence (CoE) and summarized the results using the GRADE approach. Our search strategy yielded 57,451 references. No randomized trials were identified. Sixteen studies (one controlled before-after study and 15 interrupted time series) met our inclusion criteria and were included in the review. Most studies were conducted in tertiary care general hospitals from the United States, Europe, and Asia. Eleven studies included adult patients hospitalized in general wards and intensive care units, one was carried out in a neonatal intensive care unit, two in hematology or oncology units, and one in a solid organ transplantation department. Eleven studies were conducted in the setting of an outbreak. Regarding the detection strategy used, all studies included screening strategies for high-risk patients at the moment of admission and 7 studies reported a contact surveillance strategy. Most studies were conducted in settings where infection prevention and control measures were concomitantly installed or reinforced. Data were not suitable for meta-analysis, so the results were presented as a narrative synthesis. Most studies showed a decline in the prevalence of both infection and colonization rates after the implementation of a policy of active surveillance, but the CoE is low. Screening strategies may result in little to no difference in the risk of all-cause mortality and the length of hospital stay. Existing evidence may favor the use of surveillance culture to carbapenem-resistant gram-negative bacteria, but its quality is poor, so solid conclusions cannot be drawn. Well-conducted randomized trials or high-quality quasi-experimental studies are needed to improve the certainty of the existing evidence. These studies should assess the effect of the addition of screening strategies as a single intervention and measure clinically important outcomes such as infection, length of hospital stay, and mortality.

27 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
CVC Vergara
C Vergara
CÁC Ávila
C Ávila
JCJ Castro
J Castro
JCJ Cid
J Cid
GRGabriel Rada
Gabriel Rada
Objective COVID-19 Living OVerview of Evidence (COVID-19 L·OVE) is a public repository and classification platform for COVID-19 articles. The repository contains over 430,000 articles as of 20 September 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews. Methods Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L·OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L·OVE repository. We estimated the currency as the percentage of studies that were available in the COVID-19 L·OVE repository at the time the systematic reviews conducted their own search. Results We identified 83 eligible systematic reviews that included 2132 studies. COVID-19 L·OVE had an overall comprehensiveness of 99.67% (2125/2132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L·OVE instead of searching the original sources, was 96.48% (2057/2132). Both the comprehensiveness and the currency were 100% for randomised trials (82/82). Conclusion The COVID-19 L·OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processes

28 September 2022 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Closed access
PDF file
AGAna María Rojas Gómez
Ana María Rojas Gómez
JSJuan J. Serrano
Juan J. Serrano
DRDiego Rosselli
Diego Rosselli
Objectives: To evaluate the cost-effectiveness of the nonsurgical periodontal treatment (NSPT) compared with supragingival therapy in type II diabetics with periodontitis. Methods: A decision tree analysis was used to estimate the costs and health outcomes of two periodontal therapies in a hypothetical cohort of type II diabetics with periodontitis. The analysis was developed from the perspective of a third-party payer at 1 year and 5 years. Probabilities were derived from two systematic reviews. The costs and resource use were validated by a Delphi expert panel. All costs were expressed in USD, using the 25 May 2021 Colombian pesos market exchange rate (USD 1 = COP 3,350). Results: NSPT was a dominant alternative compared with subsidized supragingival therapy in type II diabetics with periodontitis, generating savings of USD 87 and 400, during the first year or up to 5 years, respectively, and improving dental survival from 32 to 69 percent. Conclusions: NSPT can generate savings by reducing the complications derived from uncontrolled periodontitis and tooth loss.

1 April 2021 in International journal of interdisciplinary dentistry
Verified
Journal Article
Open access
PDF file
AGAna María Rojas Gómez
Ana María Rojas Gómez
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
Julián Balanta-MeloJulián Balanta-Melo
Julián Balanta-Melo
PALABRAS CLAVE: Caries; Infiltración de resina; Caries interproximal; Barniz de flúor; Tratamiento mínimamente invasivo; Epistemonikos; GRADE

17 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
GRGabriel Rada
Gabriel Rada
CACamila Avila-Oliver
Camila Avila-Oliver
JRJosé Ramos-Rojas
José Ramos-Rojas
JVJuan Vasquez-Laval
Juan Vasquez-Laval
CVCamilo Vergara
Camilo Vergara
DBDiana Biscay
Diana Biscay
Randomized controlled trials (RCTs) are the cornerstone of evidence-based healthcare, providing the most reliable means of assessing the efficacy and safety of health interventions. However, their rapidly growing volume and dispersion across diverse sources, such as bibliographic databases, preprint servers, and trial registries, pose major challenges for evidence synthesis, clinical guideline development, and health technology assessment. Despite longstanding recognition of their importance and multiple initiatives to improve accessibility, there is still no comprehensive, freely available, and continuously updated resource of trial records. To address this gap, the Epistemonikos Foundation developed the Epistemonikos Database of Trials (ED-Trials), a continuously updated repository of RCTs identified from more than 30 sources, including bibliographic databases, preprint servers, international trial registries, and other search sources. This paper describes the methods used to identify and classify trial records, outlines the key features of the search interface, and reports the database status as of October 2025. ED-Trials now includes more than 1.5 million unique trial records, many of which are not indexed in MEDLINE or other conventional bibliographic databases. It represents a significant scholarly and technical achievement, offering a freely accessible and user-friendly resource that enables more efficient, comprehensive, and up-to-date identification of randomized controlled trials, thereby strengthening the foundation of evidence-based healthcare.

1 April 2021 in International journal of interdisciplinary dentistry
Verified
Journal Article
Open access
PDF file
AGAna María Rojas Gómez
Ana María Rojas Gómez
FVFrancisca Verdugo-Paiva
Francisca Verdugo-Paiva
Julián Balanta-MeloJulián Balanta-Melo
Julián Balanta-Melo
PALABRAS CLAVE: Caries; Infiltración de resina; Caries interproximal; Barniz de flúor; Tratamiento mínimamente invasivo; Epistemonikos; GRADE